Skip to content

Clinical trials

Glomerulosclerosis, Focal Segmental trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Country / region: France Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20183
20201
20223
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
Amgen1
Boehringer Ingelheim1
Dimerix Bioscience Pty Ltd1
Nantes University Hospital1
Pfizer1
River 3 Renal Corp.1
Sanofi1
Travere Therapeutics, Inc.1
University Hospital, Limoges1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental12
Nephrosis, Lipoid5
Kidney Diseases3
Nephrotic Syndrome2
AIDS-Associated Nephropathy1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Diabetic Nephropathies1
Glomerulonephritis, IGA1
Glomerulonephritis, Membranous1
Nephritis, Hereditary1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.